Scientists defined the events that contributed to dynamic adaptation of glioblastoma (GBM) during treatment with human skin-derived induced neural stem cells releasing the pro-apoptotic agent TRAIL and developed strategies which converted initial tumor kill into sustained GBM suppression.
[Molecular Therapy Oncolytics]
